Navigation Links
Dell Laser Consultants is Among the First in Texas to offer the RxSight™ Light Adjustable Lens to Patients

Renowned eye surgical practice led by Steven J. Dell, MD, Dell Laser Consultants is among the first practices in Texas to offer the FDA-approved, post-surgical, corrective Light Adjustable Lens (LAL) by RxSight™. Since offering this technology in November 2019, nearly 100 LAL implants have been placed with excellent results. Dell Laser Consultants is also currently involved in the latest LAL FDA study.

The RxSight™ LAL is the first intraocular lens (IOL) that allows adjustments following cataract surgery, the first and only FDA-approved IOL of this nature. Before this technology, the refractive accuracy, which affects post-op visual outcomes, could not be precisely targeted, despite preoperative measurements and calculations. The LAL is a three-piece foldable design that is implanted just like a monofocal lens implant. A monofocal lens is a standard lens implant, which is typically covered by most insurance companies, such as Medicare. Unlike monofocal lenses, the Light Adjustable Lens is made with a special photoreactive silicone, which allows surgeons to adjust the prescription after implantation by using an advanced Ultra-Violet (UV) light.

Cataracts occur when the eye’s natural lens becomes clouded, most commonly the result of aging. While cataracts are one of the leading causes of blindness, the removal of cataracts is one of the safest and most common surgical procedures around in the world today. The Light Adjustable Lens technology in cataract surgery helps improve visual outcomes by allowing surgeons to make adjustments to the lens after the cataract is removed and the LAL is implanted.

“In the past, it could be difficult to get precise pre-operative measurements on patients that had previous refractive surgery such as LASIK or PRK. Now, we have the ability to fine-tune a patient’s visual results after surgery. This gives the patient the choice to correct both eyes for distance or correct the non-dominant eye for up-close vision, resulting in a more precise form of monovision. This level of precision has not been achievable until now, by using the Light Adjustable Lens,” said Dr. Steven J. Dell, Medical Director of Dell Laser Consultants.

In an FDA study which included 600 patients, those who received the LAL were twice as likely to achieve 20/20 vision without glasses, compared to those who received a standard monofocal lens.

“This technology has allowed us to offer exceptional visual results to patients that previously had to settle for lesser vision,” said Dr. Derek N. Cunningham, Director or Optometry at Dell Laser Consultants.

The ideal candidates for Light Adjustable Lens implants are patients that are concerned about their best possible distance vision, a patient wanting monovision, or patients with a history of corneal surgery including LASIK, PRK, or RK for irregular corneas.

About Dell Vision
Led by Steven J. Dell, MD, Dell Laser Consultants is a leading ophthalmology practice located in Austin, TX. Considered an international leader in refractive, cataract, and LASIK eye surgery, Dr. Dell is a board-certified ophthalmologist in Austin and the Medical Director of Dell Laser Consultants. He has dedicated his career to enhancing vision correction in the US and abroad, and he strives to provide each patient with exceptional, customized treatment and unparalleled results. An award-winning eye surgeon, Dr. Dell has been a featured presenter at major ophthalmology conferences around the world, where he helps to train other eye surgeons in the latest techniques. Furthermore, he is an advocate of continuing education, and his research has led to the development of some of the most advanced technologies available. Through his relationship with the FDA and several ophthalmic equipment manufacturers, he is able to provide patients with state-of-the-art innovations years ahead of other practices.

Read the full story at

Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved

Related biology news :

1. Future of Laser Innovations Reflected at Revamped ICALEO Conference
2. Italian Laser Manufacturer Quanta System SpA Signs Exclusive U.S. Distribution Agreement with Cartessa Aesthetics
3. Erchonia’s NEW FX 635 Laser for Chronic Low Back Pain will be Available at The National 2018
4. Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market
5. Laser-guided sea monkeys show how zooplankton migrations may affect global ocean currents
6. Symphony of nanoplasmonic and optical resonators produces laser-like light emission
7. Lasers and night-vision technology help improve imaging of hidden lymphatic system
8. Fighting cancer with lasers and nanoballoons that pop
9. Scientists prove X-ray laser can solve protein structures from scratch
10. Lasers might be the cure for brain diseases such as Alzheimers and Parkinsons
11. Lasers offer an automated way to test drinking water
Post Your Comments:
(Date:3/2/2020)... ... March 02, 2020 , ... Nominations are now being accepted for the ... Industry Association (SIA) and SecureIDNews and co-presented with sponsors IDEMIA ... The recipients of this year’s Women in Biometrics Awards will be honored at the ...
(Date:2/28/2020)... ... February 27, 2020 , ... An upcoming ... treatment solutions for maladies, such as Inflammatory Bowel Disease (IBD), specifically Crohn’s Disease ... will focus on a novel platform developed by Deka Biosciences, Inc. (Deka Biosciences), ...
(Date:2/26/2020)... ... February 25, 2020 , ... Renowned eye surgical practice led by Steven J. ... to offer the FDA-approved, post-surgical, corrective Light Adjustable Lens (LAL) by RxSight™. Since offering ... results. Dell Laser Consultants is also currently involved in the latest LAL FDA study. ...
Breaking Biology News(10 mins):
(Date:2/19/2020)... Pa. (PRWEB) , ... February 19, 2020 , ... ... and process solutions for the life sciences industry, today announced the opening of ... Kenji Nagamura, Associate Partner, Red Nucleus R&D. , Red Nucleus announced the new ...
(Date:2/11/2020)... BALTIMORE (PRWEB) , ... February 11, 2020 , ... ... biosolids and residuals solutions services in North America, today announced that the City ... long-term solution to its biosolids management needs. Commencing in April of 2020, Synagro ...
(Date:2/5/2020)... ... , ... Rare Disease Day® , held the last day in February ... (NORD), to raise awareness amongst the general public and decision-makers about rare diseases and ... Mystery” rare disease series will be shining the light on Rare Disease ...
(Date:1/28/2020)... , ... January 28, 2020 , ... ... be the exclusive distributor to food and beverage manufactures within North America. Both ... critical suppliers. This agreement will allow each company to pool their collective resources ...
Breaking Biology Technology: